Cuban vaccine might some day turn lung cancera
The first patients in a clinical trial at Roswell Park Cancer Institute have begun receiving monthly doses of CIMAvax-EGF, a Cuban lung cancer vaccine that U.S. researchers say shows promise in preventing the recurrence of lung cancer - the leading cause of cancer deaths in the United States. Cuban vaccine might turn lung cancer into chronic disease The first patients in a clinical trial at Roswell Park Cancer Institute have begun receiving monthly doses of CIMAvax-EGF, a Cuban lung cancer vaccine that U.S. researchers say shows promise in preventing the recurrence of lung cancer - the leading cause of cancer deaths in the United States.
Start the conversation, or Read more at York Dispatch.